• Explore /
  • Poster
  • / A phase II randomized trial of RAdium-223 dichloride and SABR versus SABR for oligomEtastatic prostate caNcerS (RAVENS).

A phase II randomized trial of RAdium-223 dichloride and SABR versus SABR for oligomEtastatic prostate caNcerS (RAVENS).

Abstract Poster

Authors

null

Matthew Pierre Deek

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, MD

Matthew Pierre Deek , Hamza Hasan , Ryan Phillips , Robert F Hobbs , Ana Ponce Kiess , Hao Wang , Elizabeth D Thompson , Jonathan Powell , Curtiland Deville , Stephen C. Greco , Danny Song , Steven P. Rowe , Samuel R. Denmeade , Mark Christopher Markowski , Emmanuel S. Antonarakis , Michael Anthony Carducci , Mario A. Eisenberger , Kenneth J. Pienta , Channing Judith Paller , Phuoc T. Tran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT04037358

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS5586)

DOI

10.1200/JCO.2020.38.15_suppl.TPS5586

Abstract #

TPS5586

Poster Bd #

167

Abstract Disclosures

Similar Posters

First Author: Jonathan David Tward

First Author: Zaker Hamid Rana

First Author: Bridget F. Koontz

First Author: Isobel Porter